These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11981409)

  • 21. Expression of human decay accelerating factor (hDAF) in transgenic pigs regulates complement activation during ex vivo liver perfusion--immunopathological findings.
    Pascher A; Poehlein C; Storck M; Abendroth D; Mueller-Hoecker J; Koenig W; Young VK; White DJ; Hammer C
    Transpl Int; 1996; 9 Suppl 1():S385-7. PubMed ID: 8959869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of ammonia and lidocaine clearance, and galactose elimination capacity of xenoperfused pig livers using a pharmacokinetic analysis.
    Uesugi T; Ikai I; Yagi T; Satoh S; Kanazawa A; Yoneyama T; Takeyama O; Nishitai R; Katura N; Okabe H; Terajima H; Iwata H; Yamaoka Y
    Transplantation; 1999 Jul; 68(2):209-14. PubMed ID: 10440389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The function of transgenic human DAF-expressing porcine livers during hemoperfusion with human blood.
    Pöhlein C; Pascher A; Storck M; Young VK; König W; Abendroth D; Wick M; Thiery J; White DJ; Hammer C
    Transpl Int; 1996; 9 Suppl 1():S392-6. PubMed ID: 8959871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combining the hDAF transgene with the GP IIb/IIIa inhibitor tirofiban improves heart performance and reduces myocardial damage following hyperacute rejection in an ex vivo perfusion model.
    Brandl U; Erhardt M; Joeckle H; Michel S; Brenner P; Bittmann I; Roessle M; Mordstein V; Hammer C; Schmoeckel M; Reichart B
    Transplant Proc; 2005; 37(1):491-2. PubMed ID: 15808686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ex vivo and extracorporeal perfusion with hDAF pig kidneys.
    Luo Y; Levy G; Garcia BM; Yang H; Phillips J; Noble L; Chakrabarti S; Grant D; Zhong R
    Xenotransplantation; 2003 Sep; 10(5):410-21. PubMed ID: 12950984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of hyperacute rejection by human decay accelerating factor in xenogeneic perfused working hearts.
    Schmoeckel M; Nollert G; Shahmohammadi M; Young VK; Chavez G; Kasper-König W; White DJ; Müller-Höcker J; Arendt RM; Wilbert-Lampen U; Hammer C; Reichart B
    Transplantation; 1996 Sep; 62(6):729-34. PubMed ID: 8824468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ex vivo characterization of human anti-porcine hyperacute cardiac rejection.
    Kirk AD; Heinle JS; Mault JR; Sanfilippo F
    Transplantation; 1993 Oct; 56(4):785-93. PubMed ID: 8212196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemodynamic and biochemical changes during normothermic and hypothermic sanguinous perfusion of the porcine hepatic graft.
    Ikeda T; Yanaga K; Lebeau G; Higashi H; Kakizoe S; Starzl TE
    Transplantation; 1990 Oct; 50(4):564-7. PubMed ID: 2219274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rejection of pig liver xenografts in patients with liver failure: implications for xenotransplantation.
    Tector AJ; Berho M; Fridell JA; DiCarlo A; Liu S; Soderland C; Barkun JS; Metrakos P; Tchervenkov JI
    Liver Transpl; 2001 Feb; 7(2):82-9. PubMed ID: 11172389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of hyperacute rejection in a model of orthotopic liver xenotransplantation from pig to baboon using polytransgenic pig livers (CD55, CD59, and H-transferase).
    Ramírez P; Montoya MJ; Ríos A; García Palenciano C; Majado M; Chávez R; Muñoz A; Fernández OM; Sánchez A; Segura B; Sansano T; Acosta F; Robles R; Sánchez F; Fuente T; Cascales P; González F; Ruiz D; Martínez L; Pons JA; Rodríguez JI; Yélamos J; Cowan P; d'Apice A; Parrilla P
    Transplant Proc; 2005 Nov; 37(9):4103-6. PubMed ID: 16386637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced fibrin deposition and intravascular thrombosis in hDAF transgenic pig hearts perfused with tirofiban.
    Brandl U; Jöckle H; Erhardt M; Michel S; Burdorf L; Brenner P; Bittmann I; Rössle M; Mordstein V; Hammer C; Thein E; Reichart B; Schmoeckel M
    Transplantation; 2007 Dec; 84(12):1667-76. PubMed ID: 18165780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperacute lung rejection in the pig-to-human model 4: evidence for complement and antibody independent mechanisms.
    Pfeiffer S; Zorn GL; Blair KS; Farley SM; Wu G; Schuurman HJ; White DJ; Azimzadeh AM; Pierson RN
    Transplantation; 2005 Mar; 79(6):662-71. PubMed ID: 15785372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Soluble Galalpha(1,3)Gal conjugate combined with hDAF preserves morphology and improves function of cardiac xenografts.
    Brandl U; Erhardt M; Michel S; Jöckle H; Burdorf L; Bittmann I; Rössle M; Mordstein V; Brenner P; Hammer C; Reichart B; Schmoeckel M
    Xenotransplantation; 2007 Jul; 14(4):323-32. PubMed ID: 17669174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperacute rejection in ex vivo-perfused porcine lungs transgenic for human complement regulatory proteins.
    Pöling J; Oezkur M; Kogge K; Mengel M; Niemann H; Winkler M; Haverich A; Wiebe K
    Transpl Int; 2006 Mar; 19(3):225-32. PubMed ID: 16441772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of immunoapheresis for delaying hyperacute rejection during isolated xenogeneic pig liver perfusion.
    Pascher A; Poehlein C; Stangl M; Hoebel G; Thiery J; Mueller-Derlich J; Hammer C
    Transplantation; 1997 Mar; 63(6):867-75. PubMed ID: 9089228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-duration xenogeneic extracorporeal pig liver perfusion with human blood.
    Terajima H; Shirakata Y; Yagi T; Mashima S; Shinohara H; Satoh S; Arima Y; Gomi T; Hirose T; Ikai I; Morimoto T; Inamoto T; Yamaoka Y
    Transpl Int; 1996; 9 Suppl 1():S388-91. PubMed ID: 8959870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Release of pig leukocytes and reduced human NK cell recruitment during ex vivo perfusion of HLA-E/human CD46 double-transgenic pig limbs with human blood.
    Puga Yung G; Bongoni AK; Pradier A; Madelon N; Papaserafeim M; Sfriso R; Ayares DL; Wolf E; Klymiuk N; Bähr A; Constantinescu MA; Voegelin E; Kiermeir D; Jenni H; Rieben R; Seebach JD
    Xenotransplantation; 2018 Jan; 25(1):. PubMed ID: 29057510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mean xenograft survival of 14.6 days in a small group of hDAF-transgenic pig hearts transplanted orthotopically into baboons.
    Brenner P; Schmoeckel M; Wimmer C; Eder V; Rucker A; Felbinger T; Uchita S; Hinz M; Brandl U; Meiser B; Reichenspurner H; Hammer C; Reichart B
    Transplant Proc; 2005; 37(1):472-6. PubMed ID: 15808680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The protective effects of prostaglandin E1 on sinusoidal endothelial cells in xenogeneic pig liver perfusion.
    Yagi T; Ikai I; Terajima H; Satoh S; Kanazawa A; Shinohara H; Uesugi T; Yoneyama T; Gomi T; Takahashi R; Yamamoto M; Inamoto T; Yamaoka Y
    J Surg Res; 1997 Nov; 73(1):28-34. PubMed ID: 9441789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional metabolic characteristics of intact pig livers during prolonged extracorporeal perfusion: potential for a unique biological liver-assist device.
    Borie DC; Eyraud D; Boleslawski E; Lemoine A; Sebagh M; Cramer DV; Roussi J; Imbert-Bismut F; Germain G; Hannoun L
    Transplantation; 2001 Aug; 72(3):393-405. PubMed ID: 11502966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.